Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema

Abstract

Purpose

To report the clinical outcome of patients undergoing intravitreal injection of triamcinolone acetonide as treatment of long-standing cystoid macular edema after phacoemulsification.

Design

Prospective clinical interventional cases series studies.

Methods

The study included five patients suffering from cystoid macular edema after cataract surgery. They received an intravitreal injection of 25-mg crystalline triamcinolone acetonide transconjunctivally with topical anesthesia.

Results

In the follow-up period of 6.6 ± 4.1 months, visual acuity increased from 0.26 ± 0.13 to a mean maximal visual acuity of 0.60 ± 0.19. For all patients, visual acuity improved during the follow-up by at least 0.20. Two (40%) patients developed intraocular pressure values higher than 21 mm Hg, which could be controlled by topical antiglaucomatous treatment.

Conclusions

Intravitreal triamcinolone acetonide may be a therapeutic option for long-standing cystoid macular edema after cataract surgery.